OptiBiotix Health Plc (AIM:OPTI)
8.00
-0.25 (-3.03%)
Oct 31, 2025, 4:35 PM GMT+1
OptiBiotix Health Revenue
OptiBiotix Health had revenue of 557.00K GBP in the half year ending June 30, 2025, with 58.69% growth. This brings the company's revenue in the last twelve months to 1.15M, up 102.28% year-over-year. In the year 2024, OptiBiotix Health had annual revenue of 870.00K with 35.09% growth.
Revenue (ttm)
1.15M
Revenue Growth
+102.28%
P/S Ratio
7.18
Revenue / Employee
115.10K
Employees
10
Market Cap
8.26M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 870.00K | 226.00K | 35.09% |
| Dec 31, 2023 | 644.00K | 187.00K | 40.92% |
| Dec 31, 2022 | 457.00K | -1.76M | -79.35% |
| Dec 31, 2021 | 2.21M | 689.75K | 45.28% |
| Dec 31, 2020 | 1.52M | 835.66K | 121.54% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Nov 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Nov 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Nov 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Nov 30, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| AstraZeneca | 41.24B |
| GSK plc | 32.17B |
| Haleon | 11.02B |
| Smith & Nephew | 4.33B |
| Hikma Pharmaceuticals | 2.35B |
| ConvaTec Group | 1.72B |
| Spire Healthcare Group | 1.55B |
| Genus | 672.80M |